Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$453M |
| 2 |
CELG
Celgene Corp
CELG
|
+$391M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$389M |
| 4 |
GE Aerospace
GE
|
+$378M |
| 5 |
Johnson & Johnson
JNJ
|
+$356M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$307M |
| 2 |
Costco
COST
|
+$279M |
| 3 |
Lowe's Companies
LOW
|
+$273M |
| 4 |
Microsoft
MSFT
|
+$230M |
| 5 |
Chevron
CVX
|
+$225M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.59% |
| 2 | Technology | 14.11% |
| 3 | Financials | 10.92% |
| 4 | Consumer Discretionary | 9.85% |
| 5 | Real Estate | 7.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1926
Endava
DAVA
$162M
| $4.06M | ﹤0.01% |
+100,900
| New | +$3.41M |
|
1927
Black Stone Minerals
BSM
$3.08B
| $4.05M | ﹤0.01% |
261,442
+106,742
| +69% | +$1.82M |
|
1928
Sasol
SSL
$7.36B
| $4.04M | ﹤0.01% |
162,600
-65,400
| -29% | -$1.91M |
|
1929
Virtus Investment Partners
VRTS
$1.12B
| $4.04M | ﹤0.01% |
+37,629
| New | +$4.2M |
|
|
PLYM
1930
DELISTED
Plymouth Industrial REIT
PLYM
| $4.04M | ﹤0.01% |
213,205
+134,361
| +170% | +$2.39M |
|
|
TAST
1931
DELISTED
Carrols Restaurant Group, Inc.
TAST
| $4.03M | ﹤0.01% |
445,900
-251,200
| -36% | -$2.31M |
|
1932
Syndax Pharmaceuticals
SNDX
$1.77B
| $4.02M | ﹤0.01% |
431,900
+117,300
| +37% | +$855K |
|
|
ITCL
1933
DELISTED
Banco Itau Chile American Depositary Shares (each representing one third of one (1/3) Common Share)
ITCL
| $4.02M | ﹤0.01% |
321,500
+300
| +0.1% | +$3.75K |
|
|
IAA
1934
DELISTED
IAA, Inc. Common Stock
IAA
| $4.02M | ﹤0.01% |
+103,600
| New | +$4.02M |
|
|
ROCC
1935
DELISTED
Ranger Oil Corporation Class A Common Stock
ROCC
| $4.01M | ﹤0.01% |
+130,800
| New | +$4.87M |
|
1936
PRA Group
PRAA
$762M
| $4.01M | ﹤0.01% |
142,400
-9,200
| -6% | -$260K |
|
1937
Rocky Mountain Chocolate Factory
RMCF
$15.6M
| $4.01M | ﹤0.01% |
476,923
+6,216
| +1% | +$57.7K |
|
1938
Graco
GGG
$13.4B
| $4M | ﹤0.01% |
79,700
+57,600
| +261% | +$2.9M |
|
1939
Aviat Networks
AVNW
$282M
| $3.99M | ﹤0.01% |
582,604
-1,600
| -0.3% | -$10.8K |
|
|
DERM
1940
DELISTED
Dermira, Inc.
DERM
| $3.98M | ﹤0.01% |
416,100
-125,200
| -23% | -$1.35M |
|
1941
Fabrinet
FN
$20.5B
| $3.96M | ﹤0.01% |
79,800
-210,900
| -73% | -$11.1M |
|
1942
Core Molding Technologies
CMT
$224M
| $3.96M | ﹤0.01% |
529,813
-1,607
| -0.3% | -$12.2K |
|
|
RSX
1943
DELISTED
VanEck Russia ETF
RSX
| $3.96M | ﹤0.01% |
167,395
+109,495
| +189% | +$2.4M |
|
1944
Weis Markets
WMK
$1.78B
| $3.95M | ﹤0.01% |
108,551
+13,700
| +14% | +$538K |
|
|
TRTN
1945
DELISTED
Triton International Limited
TRTN
| $3.95M | ﹤0.01% |
120,506
+6,800
| +6% | +$215K |
|
1946
Chemung Financial Corp
CHMG
$401M
| $3.93M | ﹤0.01% |
81,388
+6,288
| +8% | +$300K |
|
1947
Miller Industries
MLR
$643M
| $3.93M | ﹤0.01% |
127,900
+10,100
| +9% | +$311K |
|
|
LKFT
1948
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.83B
| $3.93M | ﹤0.01% |
30,500
-22,600
| -43% | -$2.68M |
|
|
ITI
1949
DELISTED
Iteris, Inc.
ITI
| $3.93M | ﹤0.01% |
759,400
+139,200
| +22% | +$668K |
|
1950
Heritage Insurance Holdings
HRTG
$980M
| $3.92M | ﹤0.01% |
254,700
+67,900
| +36% | +$999K |
|
Similar funds
Jim Simons's Q2 2019 Portfolio in Review
As of Q2 2019, Jim Simons held 3,913 positions worth $114B, up 3.3% from $110B the previous quarter. Its ten largest holdings account for 9.1% of the portfolio.
Jim Simons's Q2 2019 filing shows 495 new, 1,847 increased, 1,145 reduced and 397 closed positions. Its largest new stake was Apple: 9,290,160 shares worth $460M. The largest sale was UnitedHealth, an estimated $307M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Technology and Financials.
- Jim Simons's largest Q2 2019 buy was Apple: 9,290,160 shares worth $460M.
- Jim Simons added most to Celgene Corp in Q2 2019, an estimated $391M increase.
- Jim Simons's biggest Q2 2019 reduction was Microsoft, cutting an estimated $230M.
- Jim Simons fully exited UnitedHealth in Q2 2019, selling an estimated $307M.
- Jim Simons's ten largest holdings make up 9.1% of its $114B portfolio in Q2 2019.
- Jim Simons opened 495 new positions and closed 397 in Q2 2019.
- Jim Simons's portfolio value rose 3.3% quarter-over-quarter to $114B.
Based on Renaissance Technologies's 13F filing for Q2 2019, filed 12 Aug 2019.